Home›Stocks›FDMT

FDMT — structural market context

4D Molecular Therapeutics, Inc

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 14. Each line shows the earlier value, the later value and their dates.

Price

Close $12.20 (Oct 14) vs $12.36 (Oct 13): −1.29%.

Volume

0.56× its 20-session average (1.1M) on Oct 14.

Includes pre- and post-market trading.

Short interest

Short interest 11.2M shares (settlement Sep 30) vs 12.0M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 1–Sep 14, published Sep 30): 1 day with fails, largest 6 shares on Sep 10.

Previous file (settlements Aug 17–Aug 31, published Sep 16): 4 days with fails, largest 2K shares on Aug 20.

No new publication in this window.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

FDMT short interest & days to cover

SHARES SHORT
11.2M
% OF FLOAT
—
DAYS TO COVER
9.3
CHANGE VS PRIOR
-6.4%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (15d ago)

FDMT fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-10 · 35d6$14.18
2026-08-21 · 55d471$16.1
2026-08-20 · 56d2K$16.76

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

FDMT insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 9 sales

InsiderTypeSharesValueFiled
Kirn David · director, officer: See RemarksSell (S)272$4K2026-10-07
Kirn David · director, officer: See RemarksSell (S)58K$750K2026-10-07
Bizily Scott · officer: Chief Legal OfficerSell (S)2K$22K2026-09-22
Kirn David · director, officer: See RemarksSell (S)58K$811K2026-09-16
Bizily Scott · officer: Chief Legal OfficerSell (S)584$8K2026-09-03

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

FDMT analyst ratings

FirmActionRatingPublished
B.Riley Financialprice_target—2026-10-01
Bank of America SecuritiesholdBuy2026-09-29
Cantor FitzgeraldupgradeOverweight (from Neutral)2026-09-14
Cantor Fitzgeraldprice_target—2026-09-14
B. RileyholdBuy2026-08-17

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

Are insiders buying FDMT?
In the last 12 months of SEC Form 4 filings, FDMT recorded 0 insider purchases and 9 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about FDMT?
The most recent action: B.Riley Financial price_target on 2026-10-01. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell FDMT?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with F

FAST · Fastenal CompanyFBP · First BanCorp.FCCO · First Community Corporation CoFCF · First Commonwealth Financial CFIZZ · National Beverage Corp. CommonFLXS · Flexsteel Industries, Inc. ComAll F →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.